Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
The Journal of Dermatological Treatment
|
May 26, 2026
Effect of methotrexate on endothelial function in psoriasis patients
Tiago Almeida Santos Costa, Isabella Bonilha, Sheila Tatsumi Kimura Medorima, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 14, 2021
Glucose-lowering Drugs and Hospitalization for Heart Failure: A Systematic Review and Additive-effects Network Meta-analysis With More Than 500 000 Patient-years
Riobaldo M Cintra, Ana Claudia Nogueira, Isabella Bonilha, et al.
Expert Opinion on Drug Safety
|
October 8, 2024
Dapagliflozin cardiovascular effects on end-stage kidney disease (DARE-ESKD-2) trial: rationale and design
Joaquim Barreto, Marilia Martins, Mauro Pascoa, et al.
Diagnostics (Basel, Switzerland)
|
April 23, 2022
Compliance with Cardiovascular Prevention Guidelines in Type 2 Diabetes Individuals in a Middle-Income Region: A Cross-Sectional Analysis
Joaquim Barreto, Beatriz Luchiari, Vaneza L W Wolf, et al.
International Journal of Molecular Sciences
|
April 13, 2024
Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial
Isabella Bonilha, Érica Ivana Lázaro Gomes, Helison R P Carmo, et al.
Research Square
|
October 27, 2023
Dapagliflozin cardiovascular effects on end-stage kidney disease (DARE-ESKD-2) trial: rationale and design
Joaquim Barreto, Marilia Martins, Mauro Pascoa, et al.
Therapeutic Advances in Chronic Disease
|
October 16, 2020
Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial
Ikaro Breder, Jessica Cunha Breder, Isabella Bonilha, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 14, 2019
Reciprocal Multifaceted Interaction Between HDL (High-Density Lipoprotein) and Myocardial Infarction
Andrei C Sposito, José Carlos de Lima-Junior, Filipe A Moura, et al.
Cardiovascular Diabetology
|
March 27, 2026
Dapagliflozin-induced integrated improvements in left ventricular diastole, endothelial function, and arterial load: a randomized clinical trial
Sheila T Kimura-Medorima, Daniela C Oliveira, Ikaro Breder, et al.
Cardiovascular Diabetology
|
March 27, 2021
Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial
Andrei C Sposito, Ikaro Breder, Alexandre A S Soares, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
The Journal of Dermatological Treatment
|
May 26, 2026
Effect of methotrexate on endothelial function in psoriasis patients
Tiago Almeida Santos Costa, Isabella Bonilha, Sheila Tatsumi Kimura Medorima, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 14, 2021
Glucose-lowering Drugs and Hospitalization for Heart Failure: A Systematic Review and Additive-effects Network Meta-analysis With More Than 500 000 Patient-years
Riobaldo M Cintra, Ana Claudia Nogueira, Isabella Bonilha, et al.
Expert Opinion on Drug Safety
|
October 8, 2024
Dapagliflozin cardiovascular effects on end-stage kidney disease (DARE-ESKD-2) trial: rationale and design
Joaquim Barreto, Marilia Martins, Mauro Pascoa, et al.
Diagnostics (Basel, Switzerland)
|
April 23, 2022
Compliance with Cardiovascular Prevention Guidelines in Type 2 Diabetes Individuals in a Middle-Income Region: A Cross-Sectional Analysis
Joaquim Barreto, Beatriz Luchiari, Vaneza L W Wolf, et al.
International Journal of Molecular Sciences
|
April 13, 2024
Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial
Isabella Bonilha, Érica Ivana Lázaro Gomes, Helison R P Carmo, et al.
Research Square
|
October 27, 2023
Dapagliflozin cardiovascular effects on end-stage kidney disease (DARE-ESKD-2) trial: rationale and design
Joaquim Barreto, Marilia Martins, Mauro Pascoa, et al.
Therapeutic Advances in Chronic Disease
|
October 16, 2020
Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial
Ikaro Breder, Jessica Cunha Breder, Isabella Bonilha, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 14, 2019
Reciprocal Multifaceted Interaction Between HDL (High-Density Lipoprotein) and Myocardial Infarction
Andrei C Sposito, José Carlos de Lima-Junior, Filipe A Moura, et al.
Cardiovascular Diabetology
|
March 27, 2026
Dapagliflozin-induced integrated improvements in left ventricular diastole, endothelial function, and arterial load: a randomized clinical trial
Sheila T Kimura-Medorima, Daniela C Oliveira, Ikaro Breder, et al.
Cardiovascular Diabetology
|
March 27, 2021
Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial
Andrei C Sposito, Ikaro Breder, Alexandre A S Soares, et al.
Page
of 3